All good things must come to an end … and the final day of the World Glaucoma e-Congress
(WGC 2021) continued to offer vital information on new technologies and techniques to ophthalmologists beyond borders.
One such symposium from the Childhood Glaucoma Research Network was The Power and Precision of Genetics in Childhood Glaucoma:
No Longer a Shot in the Dark. And we can agree that preserving sight in everyone — and perhaps, particularly in children — is the ultimate goal.
Co-chaired by Miami, Florida, USAbased Dr. Alana Grajewski and Assoc.
Prof. Ta-Chen Chang, this symposium reviewed the genetics of childhood glaucoma, as well as potential treatment options ลาวสามัคคี.
The genes behind childhood glaucoma Primary congenital glaucoma (PCG)
is the most prevalent form of childhood glaucoma and its impact on a child’s visual development
and overall life can be devastating, began Rachida Bouhenni, PhD, from Akron Children’s Hospital (Ohio, USA) It’s Not Child’s Play.
PCG manifests during infancy before the age of 3.
“The exact mechanisms for development of PCG remain unproven; however, developmental arrest in the late embryonic stages leads to defects in the anterior chamber angle
(that includes iris insertion and compression of the trabecular beams) has been suggested,” said Dr. Bouhenni.
Three causative genes have been identified: CYP1B1, LTBP2 and TEK.
She shared that CYP1B1 is the most common causative gene and most patients with PCG caused It’s Not Child’s Play
by mutations in this gene have a severe disease phenotype.
For more information: ลาวสามัคคี